Hsbc Holdings PLC lifted its stake in Agilent Technologies, Inc. (NYSE:A – Free Report) by 2.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 753,669 shares of the medical research company’s stock after purchasing an additional 16,592 shares during the period. Hsbc Holdings PLC owned 0.27% of Agilent Technologies worth $102,642,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in the stock. SHP Wealth Management acquired a new position in Agilent Technologies during the fourth quarter valued at approximately $26,000. Core Wealth Advisors LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at $26,000. Board of the Pension Protection Fund bought a new stake in shares of Agilent Technologies in the 4th quarter valued at $27,000. Navalign LLC acquired a new stake in Agilent Technologies during the 4th quarter worth $27,000. Finally, MV Capital Management Inc. bought a new position in Agilent Technologies during the fourth quarter worth about $28,000.
Analyst Upgrades and Downgrades
A has been the subject of a number of research analyst reports. Piper Sandler initiated coverage on Agilent Technologies in a research note on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price for the company. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. UBS Group lowered their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Finally, Royal Bank Of Canada initiated coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $160.93.
Agilent Technologies Trading Up 0.3%
NYSE A opened at $127.49 on Monday. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The stock has a 50 day moving average of $121.49 and a 200-day moving average of $126.76. The company has a market cap of $36.01 billion, a PE ratio of 25.60, a PEG ratio of 2.26 and a beta of 1.26.
Agilent Technologies (NYSE:A – Get Free Report) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the company earned $1.31 earnings per share. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 6 EPS for the current fiscal year.
Agilent Technologies Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s payout ratio is currently 20.48%.
Agilent Technologies Company Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Further Reading
- Five stocks we like better than Agilent Technologies
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
